BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33073380)

  • 21. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
    Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
    Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.
    Maier-Redelsperger M; de Montalembert M; Flahault A; Neonato MG; Ducrocq R; Masson MP; Girot R; Elion J
    Blood; 1998 Jun; 91(12):4472-9. PubMed ID: 9616141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
    Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
    Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
    Menzel S; Thein SL
    Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
    Fong C; Menzel S; Lizarralde MA; Barreto G
    Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
    Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
    Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
    Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
    BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood.
    Meier ER; Byrnes C; Weissman M; Noel P; Luban NL; Miller JL
    Pediatr Blood Cancer; 2011 Jan; 56(1):103-9. PubMed ID: 21108444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
    J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
    Seakins M; Gibbs WN; Milner PF; Bertles JF
    J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of foetal haemoglobin levels and beta s haplotypes in homozygous sickle cell disease.
    Falusi AG; Kulozik AE
    Eur J Haematol; 1990 Jul; 45(1):1-4. PubMed ID: 1696209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for beta S haplotypes.
    Chang YP; Maier-Redelsperger M; Smith KD; Contu L; Ducroco R; de Montalembert M; Belloy M; Elion J; Dover GJ; Girot R
    Br J Haematol; 1997 Mar; 96(4):806-14. PubMed ID: 9074425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.
    Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA
    Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.
    Manu GP; Segbefia C; N'guessan BB; Coffie SA; Adjei GO
    Pharmgenomics Pers Med; 2022; 15():205-214. PubMed ID: 35300055
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.
    Bernaudin F; Arnaud C; Kamdem A; Hau I; Lelong F; Epaud R; Pondarré C; Pissard S
    Blood Adv; 2018 Mar; 2(6):626-637. PubMed ID: 29555644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.